Holding their own: The noncanonical roles of Smad proteins

Science Signaling

Volumn 1, Issue 46, 2008, Pages

  Hoover, Loretta L ^a   Kubalak, Steven W ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; PHOSPHORYLATION; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 58249089671     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.146pe48     Document Type: Review

References (36)

1. A. B. Roberts, M. A. Anzano, L. C. Lamb, J. M. Smith, M. B. Sporn, New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc. Natl. Acad. Sci. U.S.A. 78, 5339-5343 (1981).
2. J. Massague, TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791 (1998).
3. D. M. Kingsley, The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146 (1994).
4. C. H. Heldin, K. Miyazono, P. ten Dijke, TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471 (1997).
5. M. Lutz, P. Knaus, Integration of the TGF-β pathway into the cellular signalling network. Cell. Signal. 14, 977-988 (2002).
6. S. H. Park, Fine tuning and cross-talking of TGF-β signal by inhibitory Smads. J. Biochem. Mol. Biol. 38, 9-16 (2005).
7. X. H. Feng, R. Derynck, Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693 (2005).
8. A. Kimura, O. Katoh, H. Hyodo, A. Kuramoto, Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol. 72, 486-491 (1989).
9. Y. Chatani, S. Tanimura, N. Miyoshi, A. Hattori, M. Sato, M. Kohno, Cell type-specific modulation of cell growth by transforming growth factor β 1 does not correlate with mitogen-activated protein kinase activation. J. Biol. Chem. 270, 30686-30692 (1995).
10. L. Attisano, J. L. Wrana, Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12, 235-243 (2000).
11. H. Azuma, S. Ehata, H. Miyazaki, T. Watabe, O. Maruyama, T. Imamura, T. Sakamoto, S. Kiyama, Y. Kiyama, T. Ubai, T. Inamoto, S. Takahara, Y. Itoh, Y. Otsuki, Y. Katsuoka, K. Miyazono, S. Horie, Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. J. Natl. Cancer Inst. 97, 1734-1746 (2005).
12. D. Javelaud, V. Delmas, M. Moller, P. Sextius, J. Andre, S. Menashi, L. Larue, A. Mauviel, Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 24, 7624-7629 (2005).
13. D. Javelaud, K. S. Mohammad, C. R. McKenna, P. Fournier, F. Luciani, M. Niewolna, J. Andre, V. Delmas, L. Larue, T. A. Guise, A. Mauviel, Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res. 67, 2317-2324 (2007).
14. X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, A. Glick, Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res. 63, 7760-7768 (2003).
15. S. K. Halder, G. Rachakonda, N. G. Deane, P. K. Datta, Smad7 induces hepatic metastasis in colorectal cancer. Br. J. Cancer 99, 957-965 (2008).
16. S. K. Halder, R. D. Beauchamp, P. K. Datta, Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis. Exp. Cell Res. 307, 231-246 (2005).
17. U. Valcourt, M. Kowanetz, H. Niimi, C. H. Heldin, A. Moustakas, TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16, 1987-2002 (2005).
18. Y. Tang, Z. Liu, L. Zhao, T. L. Clemens, X. Cao, Smad7 stabilizes β-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J. Biol. Chem. 283, 23956-23963 (2008).
19. S. Imoto, K. Sugiyama, R. Muromoto, N. Sato, T. Yamamoto, T. Matsuda, Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3. J. Biol. Chem. 278, 34253-34258 (2003).
20. http://www.thebiogrid.org and http://phospho.elm.eu.org
21. D. R. Warner, E. A. Roberts, R. M. Greene, M. M. Pisano, Identification of novel Smad binding proteins. Biochem. Biophys. Res. Commun. 312, 1185-1190 (2003).
22. B. N. Davis, A. C. Hilyard, G. Lagna, A. Hata, SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61 (2008).
23. I. A. Asangani, S. A. Rasheed, D. A. Nikolova, J. H. Leupold, N. H. Colburn, S. Post, H. Allgayer, MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (2008).
24. L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, A. H. Lund, Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033 (2008).
25. S. Zhu, H. Wu, F. Wu, D. Nie, S. Sheng, Y. Y. Mo, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18, 350-359 (2008).
26. B. Schmierer, C. S. Hill, Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor β-dependent nuclear accumulation of Smads. Mol. Cell. Biol. 25, 9845-9858 (2005).
27. M. Weinstein, X. Yang, C. Deng, Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev. 11, 49-58 (2000).
28. M. P. de Caestecker, W. T. Parks, C. J. Frank, P. Castagnino, D. P. Bottaro, A. B. Roberts, R. J. Lechleider, Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 12, 1587-1592 (1998).
29. C. Dong, Z. Li, R. Alvarez Jr., X. H. Feng, P. J. Goldschmidt-Clermont, Microtubule binding to Smads may regulate TGF β activity. Mol. Cell 5, 27-34 (2000).
30. S. Zhu, W. Wang, D. C. Clarke, X. Liu, Activation of Mps1 promotes transforming growth factor-β- independent Smad signaling. J. Biol. Chem. 282, 18327-18338 (2007).
31. L. L. Hoover, E. G. Burton, M. L. O'Neill, B. A. Brooks, S. Sreedharan, N. A. Dawson, S. W. Kubalak, Retinoids regulate TGFβ signaling at the level of Smad2 phosphorylation and nuclear accumulation. Biochim. Biophys. Acta 1783, 2279-2286 (2008).
32. R. Mahmood, K. C. Flanders, G. M. Morriss-Kay, Interactions between retinoids and TGF β s in mouse morphogenesis. Development 115, 67-74 (1992).
33. Z. Yu, Y. Xing, All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-β/Smad signaling. Biochem. Biophys. Res. Commun. 340, 929-934 (2006).
34. Y. Choi, E. Fuchs, TGF-β and retinoic acid: Regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1, 791-809 (1990).
35. B. Singh, R. F. Murphy, X. Z. Ding, A. B. Roginsky, R. H. Bell Jr., T. E. Adrian, On the role of transforming growth factor-β in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells. Mol. Cancer 6, 82 (2007).
36. L. L. Hoover, S. W. Kubalak, Holding their own: The noncanonical roles of Smad proteins. Sci. Signal. 1, pe48 (2008).